Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Venue 22
About the venue
Rooms
Call for abstracts
Programme 22
Tracks 22
Speakers 22
Side events 22
Subscribe
days
hours
minutes
seconds
Structured session
Sessions
Wednesday, 23 November
10:50
Addressing substance use and substance use disorders in humanitarian settings: the role of evidence-based prevention, treatment and care
10:50
to
12:20
Insights zone 4 (I4)
Anja Busse
Current and future challenges associated with emerging cannabis markets
10:50
to
12:20
Main stage
Rosalie Pacula,
Beau Kilmer,
Tom Decorte,
Rosario Queirolo,
Chris Wilkins,
Simon Lenton
Emerging changes in Europe's cannabis situation: policy preparedness and responses to a dynamic situation
10:50
to
12:20
Knowledge market 4 (K4)
Jane Mounteney
Foetal Alcohol Syndrome: piloting best practices towards FAS/FASD prevention. Results from the FAR SEAS European project
10:50
to
12:20
Central square 1 (C1)
Joan Colom
Prescription opioids and overdose deaths
10:50
to
12:20
Knowledge market 1 (K1)
Thomas Clausen
Substance-induced psychosis: register-linkage research in Nordic countries
10:50
to
12:20
Knowledge market 2 (K2)
Solja Niemelä
13:20
Assessing the impact of laws and policies regulating illicit drugs on health and society: some insights
13:20
to
14:50
Knowledge market 4 (K4)
Peter H. Reuter
Cultures of prevention: training the workforce
13:20
to
14:50
Main stage
Gregor Burkhart
Global digital addiction interventions: adaptations to target audiences and effectiveness
13:20
to
14:50
Insights zone 2 (I2)
Matthijs Blankers
Migration, substance use and interventions in Europe
13:20
to
14:50
Insights zone 4 (I4)
Charlotte De Kock,
Klaudia Palczak
Policies for regulating cannabis supply in Europe and the US: the need for appropriate monitoring and evaluation
13:20
to
14:50
Knowledge market 1 (K1)
Liesbeth Vandam
Precision Medicine and Novel Approaches to the Treatment Alcohol Use Disorder
13:20
to
14:50
Central square 1 (C1)
Katie Witkiewitz
Prevention and control of infectious diseases among people who inject drugs: New evidence within the updated guidance from the ECDC and the EMCDDA
13:20
to
14:50
Networking zone 3 (N3)
Janelle Sandberg,
Thomas Seyler
Special at-risk populations and need for diversified interventions to prevent overdoses: insights from the US and Europe, on fentanyl, suicidal overdoses and deaths among teen-agers
13:20
to
14:50
Central square 4 (C4)
Isabelle Giraudon,
Thomas Clausen
The future for Digital Addictions Services. An update from the DigitAS-DADE Project
13:20
to
14:50
Central square 2 (C2)
Marica Ferri
15:00
Convergence in behavioural addictions
15:00
to
16:30
Main stage
Zsolt Demetrovics
Drug Early Warning Systems – the key to preparedness and response to new psychoactive substances
15:00
to
16:30
Central square 2 (C2)
Ana Gallegos,
Roumen Sedefov
How prepared are monitoring systems to respond to rapidly changing drug markets in regions bordering the European Union?
15:00
to
16:30
Insights zone 4 (I4)
Ilze Jekabsone,
Frédéric Denecker
Implementation of quality standards in drug demand reduction – where we are and where we are going?
15:00
to
16:30
Knowledge market 1 (K1)
Wouter Vanderplasschen
INDRA: dialogues for an international didactic repository for addictions
15:00
to
16:30
Insights zone 2 (I2)
Marica Ferri
Substance use and mental health disorders in Europe: prevalence, models of care, and implementation in a challenging COVID-19 context
15:00
to
16:30
Knowledge market 2 (K2)
Linda Montanari
Towards endemicity: A global perspective of the many variants of drug consumption rooms and service models in operation
15:00
to
16:30
Insights zone 3 (I3)
Amanda Roxburgh
16:50
Addiction and comorbidity over the lifespan: mechanisms and interventions
16:50
to
18:20
Central square 2 (C2)
Anna Goudriaan
Assessment of drug policies in light of Sustainable Development Goals and human rights
16:50
to
18:20
Knowledge market 1 (K1)
Eliza Kurcevič
Driving under the influence of cannabis (DUIC)
16:50
to
18:20
Insights zone 3 (I3)
Jan Ramaekers
Hepatitis C prevention and treatment among people who inject drugs: Global progress and future requirements
16:50
to
18:20
Knowledge market 3 (K3)
Jason Grebely,
Judy Chang
Impact and lessons learned in implementing and sustaining Needs-Based Planning models for substance use and mental health services and systems
16:50
to
18:20
Knowledge market 2 (K2)
Brian Rush
Scanner - Understanding the dynamics and consequences of new psychoactive substances in a rapidly changing (online) drug market
16:50
to
18:20
Insights zone 4 (I4)
Margot Balcaen
Treatment options for drug users in prisons in Central Asia and Germany
16:50
to
18:20
Networking zone 1 (N1)
Ingo Ilja Michels
Why we need evidence-based approaches for the universal measurement of cannabis: rationale and implications for public health, treatment and research
16:50
to
18:20
Main stage
Valentina Lorenzetti,
Tom Freeman
Thursday, 24 November
09:00
The Spanish Network on Research on Primary Attention on Addiction (RIAPAd): a new multilevel integrated model of responsible research on Addiction Disorders
09:00
to
10:30
Knowledge market 4 (K4)
Fernando Rodriguez De Fonseca
10:50
Cannabis use and purchase behaviours in Canada, United States, Australia, and New Zealand: Findings from the International Cannabis Policy Study
10:50
to
12:20
Knowledge market 1 (K1)
Peter H. Reuter
Current international evidence on prevalence and perceptions of Heated Tobacco Products (HTPs)
10:50
to
12:20
Insights zone 4 (I4)
Leonie Brose
From Harm to Risk Reduction: OKANA’s 360o approach in Athens
10:50
to
12:20
Knowledge market 4 (K4)
Athanasios Theocharis
How can we improve global coverage of interventions to reduce drug-related harms?
10:50
to
12:20
Main stage
Annette Verster,
Matthew Hickman
Studying illegal drugs in socially embedded markets
10:50
to
12:20
Central square 2 (C2)
Kim Moeller
Successful systemic management for addiction challenges and all its side effects
10:50
to
12:20
Central square 4 (C4)
Andrea Weiss
13:20
Cannabis and tobacco co-use: A ‘joint’ challenge for research and practice
13:20
to
14:50
Knowledge market 1 (K1)
Tom Freeman
Cannabis Social Clubs: current experiences and future directions
13:20
to
14:50
Knowledge market 4 (K4)
Mafalda Pardal
Drug checking in supervised drug consumption room: rationale, methods and results
13:20
to
14:50
Central square 4 (C4)
Frank Zobel
Environmental prevention: why do we need it now and how to advance it?
13:20
to
14:50
Insights zone 2 (I2)
Gregor Burkhart
Methods and Problems with Estimating Prevalence of People Who Inject Drugs, studies and debate on how to get better and more consistent estimates in Europe and Rest of the World
13:20
to
14:50
Central square 2 (C2)
Matthew Hickman,
Thomas Seyler
The globalised illicit drug market
13:20
to
14:50
Main stage
Roumen Sedefov
15:00
A global symposium on the renaissance and promise of psychedelics for mental and substance use disorder treatment
15:00
to
16:30
Main stage
Johannes Thrul
Drug deaths: A social, structural and systems analysis
15:00
to
16:30
Knowledge market 1 (K1)
Susanne MacGregor
Implementing Methamphetamine Prevention Strategies into Action (IMPRESA)
15:00
to
16:30
Knowledge market 4 (K4)
Marcus-Sebastian Martens
Insights into acute recreational drug and new psychoactive substance toxicity – an update from the Euro-DEN Plus Project
15:00
to
16:30
Central square 2 (C2)
Paul Dargan
The future of surveys in the field of alcohol research: Lessons learned from a large-scale European survey (DEEP SEAS project)
15:00
to
16:30
Central square 1 (C1)
Carolin Kilian
The global gambling industry: Structures, tactics, and networks of impact
15:00
to
16:30
Insights zone 3 (I3)
Janne Nikkinen
The implementation and evaluation of “safer supply” programs in Canada as a response to an ongoing overdose crisis
15:00
to
16:30
Insights zone 4 (I4)
Andrew Ivsins
16:50
How to develop global surveys, guidelines, checklists and consensus statements in prevention and treatment of addiction: new innovations in the pandemic era
16:50
to
18:20
Insights zone 4 (I4)
Hamed Ekhtiari
Opportunities and challenges for countries in transition to overcome barriers to evidence-based policies and interventions
16:50
to
18:20
Networking zone 2 (N2)
Luk Van Baelen,
Ketevan Sarajishvili
Prison and drugs: exploring social determinants and pathways to drug problem and incarceration
16:50
to
18:20
Central square 1 (C1)
Julien Morel d'Arleux,
Linda Montanari
Problem gambling: models and their ethical implications
16:50
to
18:20
Insights zone 3 (I3)
Susanne Uusitalo
Substance use, suicide and self-harm: epidemiology and prevention
16:50
to
18:20
Main stage
Julia Sinclair
Treatment for cannabis use disorder: an update focusing in cultural characteristics
16:50
to
18:20
Knowledge market 4 (K4)
Rita Jorge
Unpacking the neurobiology of cannabis use disorders and cannabinoids: findings from neuroimaging and experimental studies across different ages and world regions
16:50
to
18:20
Knowledge market 2 (K2)
Valentina Lorenzetti
18:30
On the path towards elimination of hepatitis C – Models of care to reach people who inject drugs for testing and treatment
18:30
to
19:30
Knowledge market 4 (K4)
Olav Dalgard
Friday, 25 November
10:50
EUFAS/EAR European Addiction Award
Alcohol - no ordinary commodity, alcohol policies and The Gut-Brain Axis in AUD
10:50
to
12:20
Main stage
Anna Goudriaan
Associations of alcohol and substance use with mental health
10:50
to
12:20
Knowledge market 2 (K2)
Abi Rose
COVID-19-adapted addiction services and impact for service users
10:50
to
12:20
Insights zone 4 (I4)
Pekka Hakkarainen
Gender differences and gender identities in drug use, addiction and interventions: why gender matters
10:50
to
12:20
Networking zone 3 (N3)
EGD European Group on Gender and Drugs
Investigating adolescent substance use and risk behaviours in the Mediterranean region: where do we stand?
10:50
to
12:20
Networking zone 4 (N4)
Florence Mabileau
Portuguese Drug Policy Model. Achievements and challenges
10:50
to
12:20
Central square 2 (C2)
Alcina Correia
13:20
Barriers in the implementation of harm reduction interventions in European prisons. From evidence to practice
13:20
to
14:50
Main stage
Linda Montanari,
Liesbeth Vandam
Cross-domain prevention: Preventing substance use (disorders) and antisocial behaviour together, importance of intersectoral action in prevention
13:20
to
14:50
Insights zone 2 (I2)
Elena Gervilla
Navigating the future of supervised consumption research and intervention: European and North American experiences
13:20
to
14:50
Central square 2 (C2)
Ryan McNeil
New advances in alcohol clinical research: evidence from three large National Institute for Health Research-funded randomised controlled trials
13:20
to
14:50
Networking zone 3 (N3)
Colin Drummond
Stress and Addiction: Updates on the Chicken or Egg question
13:20
to
14:50
Central square 4 (C4)
Sara Kroll,
Isabell M. Meier
The experience of persons in homeless situation with alcohol related problems regarding a pharmacological harm reduction initiative
13:20
to
14:50
Knowledge market 4 (K4)
Sónia Dias